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Abstract
To investigate whether rubella virus (RUB) undergoes intermolecular RNA–RNA recombination, cells were cotransfected with pairs of
in vitro transcripts from genomic cDNA plasmid vectors engineered to contain nonoverlapping deletions: the replicative transcript
maintained the 5-proximal nonstructural (NS) ORF (which contained the replicase, making it RNA replication competent), had a deletion
in the 3-proximal structural protein (SP) ORF, and maintained the 3 end of the genome, including the putative 3 cis-acting elements
(CSE), while the nonreplicative transcript consisted of the 3 half of the genome including the SP-ORF and 3 CSE. Cotransfection yielded
plaque-forming virus that synthesized the standard genomic and subgenomic RNAs and thus was generated by RNA–RNA recombination.
Using transcripts tagged with a 3-terminal deletion, it was found that recombinants contained the 3 end derived from the replicative strand,
indicating a cis-preference for initiation of negative-strand synthesis. In cotransfections in which the replicative transcript lacked the 3 CSE,
recombination occurred, albeit at lower efficiency, indicating that initiation in trans from the NS-ORF can occur. The 3 CSE was sufficient
as a nonreplicative transcript, showing that it can serve as a promoter for negative-strand RNA synthesis. While deletion mutagenesis
showed that the presence of the junction untranslated region (J-UTR) between the ORFs appeared to be necessary on both transcripts for
recombination in this region of the genome, analysis with transcripts tagged with restriction sites showed that the J-UTR was not a hot spot
for recombination compared to neighboring regions in both ORFs. Sequence analysis of recombinants revealed that both precise
(homologous) and imprecise recombination (aberrant, homologous resulting in duplications) occurred; however, imprecise recombination
only involved the J-UTR or the 3 end of the NS-ORF and the J-UTR (maintaining the NS-ORF), indicating selection pressure against
duplications in other regions of the genome.
© 2003 Elsevier Science (USA). All rights reserved.
Introduction
A number of positive-strand RNA viruses of animals and
plants, including members of the picornavirus, togavirus,
flavivirus, arterivirus, coronavirus, bromovirus, tombusvi-
rus, and carmovirus families, have been shown to undergo
RNA–RNA recombination (reviewed in Lai, 1992; Nagy
and Simon, 1997) and RNA–RNA recombination appears to
be a strong driving force in RNA virus evolution (Strauss
and Strauss, 1998), both within virus genera (eg. Hahn et al.,
1988; Kew et al., 2002) and among virus families (e.g.,
Zhang et al., 1992). Kirkegaard and Baltimore (1986) pro-
vided evidence for a copy-choice or template-switching
mechanism for RNA recombination in poliovirus in which
the viral RNA-dependent–RNA polymerase (RdRp)-nas-
cent progeny strand complex switches templates during
negative-strand transcription of a positive-strand template,
leaving one template (the donor strand) and continuing
synthesis of the progeny strand on a second template (the
acceptor strand). Most subsequent studies have provided
evidence consistent with recombination occurring during
RNA replication as a result of template switching, during
either negative- or positive-strand synthesis, and template
switching has been demonstrated in vitro with highly puri-
fied viral RdRps (Arnold and Cameron, 1999; Kim and Kao,
2001); however, recombination due to a nonreplicative
mechanism has been reported (Gmyl et al., 1999). Both
homologous and nonhomologous recombination have been
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documented and high-frequency recombination sites or “hot
spots” have been described (Lai, 1992; Nagy and Simon,
1997).
Rubella virus (RUB) is the only member of the Rubivirus
genus of the family Togaviridae. The RUB genomic RNA is
a single-stranded, 9762-nt, positive-sense RNA that con-
tains two long open reading frames (ORFs): a 5-proximal
ORF which encodes nonstructural proteins (NSP) that func-
tion primarily in viral RNA replication, including the RdRp,
and a 3-proximal ORF which encodes the virion structural
proteins (SP), the capsid protein (C), and two envelope
glycoproteins, E1 and E2. The genomic RNA serves as a
template for synthesis of a complementary minus-strand
RNA which is the template for synthesis of both the
genomic RNA and the subgenomic (SG) RNA, from which
the structural proteins are translated (Frey, 1994). Same-
strand, intramolecular recombination by RUB has been re-
ported and studied using genomic cDNA plasmid vectors in
which the subgenomic promoter (SGP) for SG RNA syn-
thesis, which lies in the “junction” untranslated region (J-
UTR) between the ORFs, has been duplicated for expres-
sion of foreign genes (Pugachev et al., 2000; Tzeng and
Frey, 2002). Recombination between the two SGPs of these
vectors resulted in deletion of the foreign gene and recon-
stitution of the wild-type (wt) virus genome. Sequence anal-
ysis of recombinants showed that both homologous recom-
bination (precise recombination resulting in a wt sequence
as defined by Lai, 1992) and aberrant homologous recom-
bination (imprecise recombination between homologous
templates resulting in duplications) within the SGP oc-
curred.
RNA recombination has been well studied in the Alpha-
viruses, the other Togavirus genus, particularly with Sindbis
virus (SIN). Infectious recombinants were initially recov-
ered when cells were cotransfected with different combina-
tions of in vitro transcripts from genomic cDNA plasmid
vectors bearing nonoverlapping deletions that rendered
them noninfectious (Weiss and Schlesinger, 1991; Raju et
al., 1995). Of the pair of transcripts, one was “replicative”
since it preserved the NS-ORF plus the 5 and 3 ends of the
genome (containing cis-acting elements, or CSEs) and thus
was capable of RNA replication, while the second transcript
was “nonreplicative” since it did not contain a complete
copy of the NS-ORF and lacked one or both of the CSEs.
Homologous, aberrant homologous, and nonhomologous re-
combination were detected (nonhomologous recombination
results from participation of a nonhomologous template
resulting in incorporation of unrelated sequence into the
recombinant; Lai, 1992). Sequence analysis of the 3UTR of
recombinants suggested that only limited homology existed
between the substrate templates at sites of recombination
(Hajjou et al., 1996). Additionally, it was found that a short
RNA consisting of a conserved motif within the 3UTR plus
a poly(A) tail was sufficient to serve as a donor for recom-
bination with an acceptor transcript in which the 3UTR was
replaced with nonviral sequences (Hill et al., 1997). This
result indicated that negative-strand RNA synthesis could
initiate on the 3UTR/poly(A) fragment and thus it was the
only sequence necessary for initiation of negative-strand
RNA synthesis.
In this study, we investigated RUB intermolecular RNA–
RNA recombination between replicating and nonreplicating
RNA transcripts containing nonoverlapping deletions. Con-
sidering the previous studies on SIN that used recombina-
tion to define the minimal signal for negative-strand initia-
tion, we were additionally interested in taking a similar
approach to define the minimal RUB 3CSE’s required for
negative-strand initiation. The 3-terminal 305 nts of the
genome are retained in RUB DI RNAs generated during
undiluted serial passaging, implying that the 3CSE are
located within this region, which includes both the 3SP-
coding sequences and the 60-nt 3UTR (Frey and Hemphill,
1988; Derdeyn and Frey, 1995). In addition to functioning
as a CSE, this region of the RUB genome is also of interest
because a stem-loop (SL) structure within it binds an au-
toantigen, calreticulin (CAL) (Nakhasi et al., 1990; Singh et
al., 1994). Mutagenic analysis of the CAL-binding SL, the
3UTR, and poly(A) tract within the 3–305-nt region using
a RUB genomic cDNA plasmid vector revealed that most of
the 3UTR is critical for replication with the exception of
the 3-five nucleotides and the poly(A) tract (which was
rapidly regenerated in vivo) (Chen and Frey, 1999). Addi-
tionally, it was found that mutations which destabilized
CAL binding to the SL had no effect on replication. How-
ever, because most of the 3-305-nt region encodes E1,
extensive mutagenesis of the region could not be done using
a genomic cDNA vector. Therefore, the ability to segregate
this region as a recombination donor offers the opportunity
to test which parts of it are necessary for negative-strand
initiation.
Results
RUB has not yet been reported to undergo intermolecular
RNA–RNA recombination. Following cotransfection of
Vero cells with transcripts from a replicative, defective-
interfering RNA construct with a deletion in the SP-ORF
(DI-P3) that maintains the NS-ORF and thus is capable of
RNA replication (Tzeng et al., 2001) and a nonreplicative
(NR) construct containing the 3 half of the RUB genome
(NR-5355-3; the designation indicates that the construct is
nonreplicative and contains the sequences from nt 5355
through the 3 end of the genome) (Fig. 1A), cytopathic
effect (CPE) was observed and plaque-forming virus was
recovered from the transfected culture medium. Neither
CPE nor recovery of plaque-forming virus occurred follow-
ing transfection with either transcript by itself, suggesting
that recombination between the transcripts had occurred,
resulting in generation of virus. This experiment was re-
peated with transcripts from NR-5355-3 and several repli-
cative DI constructs with SP-ORF deletions with similar
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Fig. 1. Initial transcript pairs that yielded recombinants. At the top of (A) is a diagram of the RUB genome (ORFs as boxes, UTRs as lines); the vertical line
in the J-UTR represents the SG RNA start site. Recombination was initially observed when the four replicating transcripts shown with deletions in the
SP-ORF (the nt number in the RUB genome of the deletion breakpoints along with restriction sites used to generate the deletions are given;deletions are
indicated by dotted lines) were individually used in cotransfections with the nonreplicating transcript NR-5355-3. Virus from nine recombinant plaques
generated from DI-Stu X NR-5355-3 cotransfections were amplified in Vero cells. The amplified stocks were used to infect Vero cells and intracellular RNA
was extracted and Northern analysis was used to characterize the viral RNAs present as shown in (B). The positions of migration of Robo402, DI-Stu, and
NR-5355-3 transcripts electrophoresed in the same gel are shown in the left margin, while the genome (G), subgenome (SG), and 28S rRNA (which results
in a white space) are indicated in the right margin. The RNA of five of these recombinants (2, 3, 4, 5, and 6) was sequenced across the region of overlap
between the parental transcripts; the sequence of three of these recombinants was wild-type, while the other two recombinants had duplications in the 3 end
of the NS-ORF and J-UTR, as shown at the bottom (A). To test the effect of transfection reagent on recovery of recombinant virus, seven plates of Vero
cells were cotransfected with DI-Stu and NR-5355-3 transcripts using either Lipofectamine or Lipofectamine 2000. On days 4–10 posttransfection, the
medium from one plate of cells was harvested and the virus present was titered by plaque assay; daily recovery of plaque-forming virus is shown in (C).
results (Fig. 1A). Plates transfected with transcripts from
NR-5355-3 and one of the SP-ORF deletion constructs,
DI-Stu, were overlaid with plaque assay agar; plaques were
picked and after one round of amplification used to infect
Vero cells and the virus-specific RNAs produced were an-
alyzed. As shown in Fig. 1B, virus from all of the plaques
produced RNAs corresponding to the genomic and SG
RNAs, indicating that RNA–RNA recombination had oc-
curred between the transcripts, resulting in generation of wt
virus, rather than replication and copackaging of transcripts
as has been observed with SIN (Geigenmuller-Gnirke et al.,
1991; Weiss and Schlesinger, 1991).
Two of the recombinants (3 and 5) had genomic RNAs
that were larger than the wt genomic RNA and recombinant
5 also produced a SG RNA larger than the wt SG RNA. To
determine if duplications or insertions occurred during re-
combination, after an additional round of amplification,
intracellular infected cell RNA was extracted and the re-
gions of overlap between the parental transcripts were se-
quenced for recombinants 3 and 5 as well as recombinants
2, 4, and 6, which had both wt-sized genome and SG RNAs.
No insertions or deletions were detected in the 3 region of
parental overlap with any of these recombinants nor were
insertions or deletions detected in the NS-ORF/J-UTR/SP-
ORF region of parental overlap in recombinants 2, 4, or 6.
Recombinant 3 was found to have a tandem duplication of
6 nts in the J-UTR; it was surprising that such a small
duplication would retard the mobility of the genomic RNA
to the extent observed in the gel in Fig. 1B. Recombinant 5
was found to have a tandem duplication of nts 6353–6434
encompassing the 3 end of the NS-ORF and the J-UTR
through 2 nts upstream from the SG start site.
In another experiment, the parental regions of overlap in
seven recombinant viruses plaque-purified from culture
fluid from a plate cotransfected with DI-Stu and NR-5355-
33 transcripts were sequenced with the result that only
point mutations, but no deletions or insertions, in the re-
gions of parental overlap were detected.
In subsequent experiments, following cotransfections
with pairs of replicative and nonreplicative transcripts, the
cells were examined daily for CPE. Following the appear-
ance of putative CPE, the transfected cell-culture fluid was
used to infect fresh monolayers of cells, which were then
examined for the development of CPE to confirm that re-
combinant virus had been produced. Cotransfections were
repeated at least three times to ensure that the production of
virus through recombination between a pair of transcripts
was reproducible. In the course of these experiments, both
Lipofectamine and Lipofectamine 2000 were used as trans-
fection reagents. In our hands using RUB replicons express-
ing the GFP reporter gene, Lipofectamine 2000 was roughly
seven times more efficient based on the number of cells
expressing GFP following transfection of a standard amount
of transcripts (5% of the cells fluorescing following Lipo-
fectamine-mediated transfection vs 35% following Lipo-
fectamine 2000 mediated transfection). The different trans-
fection reagents also affected the kinetics of appearance of
CPE following cotransfection with replicating and nonrep-
licating transcripts. In a typical cotransfection experiment
with DI-Stu and NR-5355-3, CPE was first observed 5 days
posttransfection when Lipofectamine 2000 was used and 8
days posttransfection when Lipofectamine was used. As
shown in Fig. 1C, detection of plaque-forming virus coin-
cided with appearance of CPE and occurred 3 days earlier
following Lipofectamine 2000 than Lipofectamine-medi-
ated transfection. As will be shown later, the use of trans-
fection reagent affected recovery of recombinants following
cotransfections with specific replicative and nonreplicative
transcript pairs; in these cases, recombination was detect-
able if Lipofectamine 2000 was used, but not if Lipo-
fectamine was used. We interpret this to indicate that trans-
fection efficiency was higher with Lipofectamine 2000 in
terms of delivery of transcripts to individual cells as well as
to number of cells transfected, resulting in more cells con-
taining both transcripts and the presence of more intracel-
lular transcripts in individual cells on which recombination
could occur. Alternatively, the presence of more transcripts
delivered to individual cells by Lipofectamine 2000 could
have increased the functional half-life during which tran-
scripts were available in the cell for recombination to occur.
Recombination in the junction region
The standard transcript pair in a recombination assay
shown in Fig. 1 overlapped in two regions of the genome:
the region containing the 3 end of the NS-ORF through the
J-UTR and the 5 end of the SP-ORF (1535–1959 nts,
depending on the replicative transcript used); and the region
at the 3 end of the genome (310–591 nts). To produce
virus, minimally one recombination in the former region
needs to occur. To investigate the requirements for recom-
bination in this region, a series of cotransfections was per-
formed with transcripts containing deletions as shown in
Fig. 2 and Table 1. When the overlap was minimized less
than 100 nts in the SP-ORF (DI-AB or DI-325 cotransfected
with NR-7318-3; a region of overlap of 8 and 95 nts,
respectively), no recombination was detected. When the
SP-ORF was replaced with the GFP reporter gene in the
replicative transcript (RUBrep/GFP), recombination was
still detected when NR-5355-3 was used as the nonrepli-
cative transcript. A series of constructs that progressively
deleted the 5 end of the nonreplicative NR-5355-3 tran-
scripts was used in cotransfections with RUBre/GFP. Tran-
scripts which retained part of the NS-ORF (NR-6263-3 and
NR-6313-3) yielded recombinants, while transcripts de-
leted into the J-UTR (NR-6408-3 and NR-6436-3) did not.
The region of overlap in these latter two cotransfections was
reduced to 108 and 76 nts, respectively; however, when the
same series of transcripts as used in cotransfections with
DI-Stu, the same observations were made even though the
region of overlap with NR-6408-3 and NR 6436-3 was
increased to 553 and 525 nts, respectively. When Lipo-
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fectamine 2000 was used as the transfection reagent, recom-
binants were recovered when NR-6408-3 and NR-6436-3
were cotransfected with RUBrep/GFP or DI-Stu, indicating
that although recombination occurred, it was inefficient.
These observations suggested that the J-UTR was a poten-
tial hot spot for recombination relative to the neighboring
sequences in the NS- and SP-ORFs or that its presence in
the donor strand might be necessary for recombination to
occur in this region of the genome. To determine whether or
to what extent the J-UTR could be deleted while preserving
the ability of recombination to occur, an extensive series of
constructs that introduced deletions at the 5 end of the
nonreplicative transcript through the junction UTR was
made and these transcripts were cotransfected with DI-Stu
transcripts using Lipofectamine 2000 reagent. As shown in
Table 1, the minimal nonreplicative transcript that yielded
recombinants was NR-6479-3, the 5 end of which still
contains the thirty-three 3 nt of the J-UTR (although the
overlap with DI-Stu was 482 nts). In cotransfections be-
tween DI-Stu and nonreplicative constructs with deletions
extending beyond nt 6436, the appearance of CPE was
delayed (Table 1).
To resolve whether the J-UTR was a hot spot for recom-
bination, transcripts were used that were genetically tagged
with restriction sites at either end of the J-UTR: NsiI was
introduced at the 5 end of the J-UTR to produce NDI-Stu
and NNR-5355-3, while XbaI was introduced at the 3 end
of the J-UTR to produce XDI-Stu and XNR-5355-3;
Robo502 virus with either of these restriction sites produces
titers equivalent to Robo502 virus; Robo502 and XRobo502
virus produce similar plaques, and NRobo502 virus pro-
duces smaller plaques. As shown in Fig. 2B, when NDI-Stu
and XNR-5355-3 transcripts were combined in a cotrans-
fection (Lipofectamine 2000) followed by overlaying the
transfection plate with plaque assay agar, isolation, and
analysis of individual plaques, only recombinants with the
parental J-UTRs were recovered. This indicated that recom-
bination had occurred either upstream (recombinants with
XbaI site) or downstream (recombinants with NsiI site)
from, but not within, the J-UTR. When the reciprocal re-
combination assay was done, XDI-Stu/NNR-5355-3, of 10
recombinants analyzed, 3 had parental J-UTRs (two with
XbaI and one with NsiI); 2 had a recombinant J-UTR (nei-
ther site), while 5 had tandem duplications: 1 within the
J-UTR and 4 including both the 3 end of the NS-ORF and
the 5 end of the J-UTR. In each of these latter four recom-
binants, the upstream duplication lacked the NsiI site, while
the downstream duplication contained it, indicating that in
all four cases transcription had proceeded into the NS-ORF
on the nonreplicative transcript (NNR-5355-3) and then
Fig. 2. Recombination in the J-UTR. Genomic diagrams of pairs of replicating and nonreplicating transcripts are shown in (A) that either failed to yield
recombinants (NO RECOMBINATION) or yielded recombinants (RECOMBINATION) when Lipofectamine was used as the transfection reagent. Brackets
indicate nonreplicating transcripts used individually in cotransfections with a common replicating transcript with a similar result. In some cases, transcript
pairs that failed to yield recombinants following Lipofectaine-mediated transfection did yield recombinants when Lipofectamine 2000 was used, as indicated
by an asterisk. To determine whether the J-UTR was a recombinational hot spot, DI-Stu and NR-5355-3 transcripts generated from constructs that had been
genetically tagged with restriction sites (NsiI at the 5 end of the J-UTR or XbaI at the 3 end of the J-UTR) were used in cotransfections (Lipofectamine
2000) and virus recovered from recombinant plaques was sequenced across the region of overlap in the middle of the genome. As shown in (B), recombinants
were recovered that had no exchange of the parental markers, exchange of parental markers, and duplications of the 3 NS-ORF and J-UTR.
262 S.D. Adams et al. / Virology 309 (2003) 258–271
switched to the replicating template (XDI-StuI) within the
J-UTR (such an event would have produced recombinant 5
in Fig. 1). Thus of the 18 recombinants tested, the J-UTR
was not involved in 11 recombination events, was the site of
recombination in 3, and participated in recombination with
the NS-ORF in 4. Therefore, while the J-UTR could be
involved in recombination, it was not the only site at which
recombination occurred. The asymmetry of the results in
this experiment (i.e., the recombination within the J-UTR
when the genetic tags were in one orientation, but not the
other) could have been due to selection against recombi-
nants with both restriction sites that would have resulted
from a recombination event in the J-UTR in the NDI-Stu/
XNR-5355-3 cotransfection. However, a Robo502 con-
struct engineered to contain both sites yielded virus with a
wild-type phenotype.
Recombination at the 3 end of the genome
When DI-Stu transcripts were cotransfected with non-
replicative transcripts from NR-5355-3 constructs in which
the 3UTR had either been deleted (NR-5355-3UTR) or
replaced with the 3UTR from SIN (NR-5355-SIN3UTR),
recombinants were recovered when both Lipofectamine and
Lipofectamine 2000 were used as the transfection reagent
(Fig. 3A). Recombination between replicative constructs
that lacked the 3CSE and nonreplicative constructs that
contained the 3CSE was next explored. It has not been
demonstrated that a construct containing the 5CSE and
NS-ORF but lacking the 3CSE can undergo RNA replica-
tion; however, these constructs were considered replicative
in the context of these experiments because they contained
the NS-ORF and thus could theoretically produce the viral
replicase. Unexpectedly, when the 3UTR was only present
on the nonreplicative transcript, recombination was not de-
tected when Lipofectamine was used as the transfection
reagent. This included cotransfections with transcripts with
minimal overlap [R-5-7318/NR-7318-3; R-5-7318 de-
notes a replicative (R) transcript containing sequences from
the 5 end of the genome through nt 7318], with transcripts
with overlap in the 3NS-ORF/J-UTR/5SP-ORF region (R-
5-7318/NR-5355-3), and with replicative transcripts lack-
ing only the 3UTR (R-3UTR; replicative transcript lack-
ing the 3UTR) or with the 3UTR replaced with the SIN
3UTR (R-SIN3UTR) or nonviral vector sequences (R-
3NVS) and the standard NR-5355-3 nonreplicative tran-
script. When Lipofectamine 2000 was used as the transfec-
tion reagent, recombinants were recovered from these
cotransfections, with the exception of the R-5-7318/NR-
7318-3 cotransfection of transcript with minimal overlap.
Additionally, using Lipofectamine 2000, recombinants were
recovered from cotransfections with the R-3UTR,
Table 1
Recombination between transcripts with sequential deletions across the junction UTR
Replicating Transcripta Nonreplicating Transcripta Lipoa,b Lipo2000a,b
DI-AB (7318-9174) NR-7318-3  
DI-325 (7412-9174) NR-7318-3  
RUBrep/GFP (6512-9934) NR-5355-3  
NR-6263-3  
NR-6313-3  
NR-6408-3  
NR-6436-3  
DI-Stu (6936-9334) NR-5355-3  
NR-6263-3  
NR-6313-3  
NR-6408-3  
NR-6436-3  
NR-6462-3 ND *
NR-6467-3 ND *
NR-6473-3 ND *
NR-6479-3 ND *
NR-6486-3 ND 
NR-6622-3 ND 
NR-6651-3 ND 
NR-6751-3 ND 
NR-6851-3 ND 
NR-6951-3 ND 
a Vero cells were co-transfected with the indicated replicating and non-replicating transcripts; each replicating transcript contained a deletion in the SP-ORF
(extent indicated) while each non-replicating transcript contained the 3 end of the genome starting at the indicated nt (the J-UTR covers nts 6388–6512).
Transfection was done either using Lipofectamine (Lipo) or Lipofectamine 2000 (Lipo2000) as the transfection reagent. : recombination observed; :
recombination not observed; ND: not done.
b With transcript pairs that produced recombinants, CPE was usually observed 8–12 days post-transfection when Lipofectamine was used and 5–8 days
post-transfection when Lipofectamine 2000 was used. Co-transfections in which appearance was delayed (9–10 days post-transfection with Lipofectamine
2000) are marked with an *.
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R-SIN3UTR, or R-3NVS replicative transcripts and a
nonreplicative transcript consisting of the 3CSE, but not a
nonreplicative transcript consisting of the 3UTR.
It was previously shown that RUB replication is prefer-
ential, if not exclusive, for templates that contain both the
5UTR and the NS-ORF in cis with the 3CSE (Liang and
Gillam, 2000; Tzeng et al., 2001). Therefore, we reasoned
that replication initiated preferentially at the 3 end of tem-
plates which contained the NS-ORF and 3CSE in cis and
that recombination to produce virus resulted if replication
subsequently switched to the nonreplicating transcript and
then back to the replicating transcript (Fig. 3Bi). Much less
Fig. 3. Recombination at the 3 end of the genome. Genomic diagrams of pairs of replicating and nonreplicating transcripts are shown in (A) that either failed
to yield recombinants (NO RECOMBINATION) or yielded recombinants (RECOMBINATION) when Lipofectamine was used as the transfection reagent.
Brackets indicate both replicating and nonreplicating transcripts used individually in cotransfections with a common replicating transcript(s) with a similar
result. In some cases, transcript pairs that failed to yield recombinants following Lipofectaine-mediated transfection did yield recombinants when
Lipofectamine 2000 was used, as indicated by an asterisk. In (B) is shown a model based on observations reported in (A) and previous reports that initiation
of negative-strand synthesis is preferential for the NS-ORF and 3CSE in cis. When one of the transcripts has the NS-ORF and 3CSE in cis (i),
negative-strand initiation and subsequent recombination is efficient to the extent that recombination is observed when Lipofectamine is used as the
transfection reagent. When the NS-ORF and 3CSE are in trans (iv), negative-strand initiation and recombination are less efficient and recombination is only
observed when Lipofectamine 2000 is employed. This model predicts that when the NS-ORF and 3CSE are available either in cis or in trans (ii and iii),
initiation of minus-strand synthesis will occur preferentially on the 3CSE in cis with the NS-ORF. To determine from which transcript the 3 end of the
recombinant was derived in such a situation, DI-Stu and NR-5355-3 transcripts generated from constructs with a wt 3 end or a construct with a deletion
of 5 nt from the 3 end of the genome [these constructs maintained the poly(A) tract] were used in cotransfections (Lipofectamine 2000) and virus recovered
from recombinant plaques was sequenced across the region of overlap at the 3 end of the genome. As shown in (C), recombinants uniformly had the 3 end
derived from the replicating parental transcript (DI-Stu).
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efficiently, recombination resulted from initiation at the 3
end of the nonreplicating template followed by template
switching to the replicating transcript, such that it was only
observed when Lipofectamine 2000 was used as the trans-
fection reagent (Fig. 3Biii). To test this hypothesis, a genetic
tag consisting of a deletion of the 3 five nts preceding the
poly(A) tract (Chen and Frey, 1999) was introduced into
one of the transcripts used in a DI-Stu/NR-5355-3 cotrans-
fection using Lipofectamine 2000 reagent. As shown in Fig.
3C, when DI-Stu transcripts with the 5 tag were cotrans-
fected with NR-5355-3 transcripts, all of the recombinants
had the 5 tag. When the reciprocal cotransfection (DI-Stu/
NR-5355-35) was done, none of the recombinants had the
5 tag. This demonstrated that when both constructs con-
tained the 3CSE (Fig. 3Bii and 3Biv), initiation of repli-
cation occurred on the transcript with the 3 end in cis with
the NS-ORF, confirming our hypothesis.
Discussion
This study provides the first evidence that RUB can
undergo intermolecular RNA–RNA recombination. We pre-
viously showed that intramolecular recombination could
occur, specifically between the SGPs of double subgenomic
expression vectors resulting in deletion of the expressed
foreign gene (Pugachev et al., 2000; Tzeng and Frey, 2002).
To detect intermolecular recombination, cotransfection with
transcripts containing nonoverlapping deletions was em-
ployed. One of these transcripts contained the 5 end of the
genome, including the 5CSE through the NS-ORF and
J-UTR, a deletion in the SP-ORF, and the 3CSE, and
therefore was capable of RNA replication. The other tran-
script, a nonreplicative transcript, contained the 3 half of
the genome beginning from the 3 end of the NS-ORF.
Plaque-forming virus was recovered that synthesized the
standard genomic and subgenomic RNAs, demonstrating
that RNA–RNA recombination between the transcripts had
occurred to generate the standard viral genome rather than
replication and copackaging of the transcripts as has been
reported with alphaviruses (Geigenmuller-Gnirke et al.,
1991; Weiss and Schlesinger, 1991). To account for incor-
poration of sequences from both transcripts into the recom-
binant virus, it is presumed that recombination occurs due to
template switching by the viral RdRp during negative-
strand RNA synthesis (Kirkegaard and Baltimore, 1986).
The initial replicative transcripts contained the 3CSE in
cis with the 5CSE and NS-ORF; the nonreplicative tran-
scripts contained the 3CSE as well. Transfections with
replicative transcripts that lacked the 3CSE failed to yield
recombinants when the lower efficiency transfection reagent
Lipofectamine was employed, but were successful when the
higher efficiency transfection reagent Lipofectamine 2000
was used. A requirement for the presence of the 3CSE in
cis with the NS-ORF for RNA replication was recently
demonstrated in two studies (Liang and Gillam, 2001;
Tzeng et al., 2001) and we therefore reasoned that negative-
strand RNA synthesis initiated preferentially on the repli-
cative transcript with the 3CSE in cis with the NS-ORF
followed by copy choice transfer of the replication complex
to the nonreplicative transcript, resulting in recombination.
At a lower efficiency, only detectable when Lipofectamine
2000 was employed as the transfection reagent, initiation
occurred on transcripts with the 3CSE in trans from the
NS-ORF. Transcripts genetically tagged with a deletion at
the exact 3 end of the genome were used to prove that in
the standard cotransfection in which both the replicative and
the nonreplicative transcripts contained the 3CSE; the
3CSE in the recombinant was derived from the replicative
transcript, even when Lipofectamine 2000 was used, as
predicted by our hypothesis. Interestingly, this means that
the recombinants recovered from the standard cotransfec-
tion were predominantly, if not exclusively, double recom-
binants, as shown in Fig. 2Bii. The recovery of recombi-
nants from cotransfected transcripts with the NS-ORF and
the 3CSE in trans is the first demonstration that RUB
negative-strand RNA synthesis can be initiated in trans.
Studies on recombination using SIN virus showed that a
transcript consisting of the 3 twenty-nucleotides plus the
poly(A) tail was sufficient as a nonreplicative transcript
when the replicative transcript was the genome with the
3UTR replaced with nonviral-plasmid vector sequences,
indicating that negative-strand RNA synthesis can initiate
on this small 3-terminal sequence (Hajjou et al., 1996; Hill
et al., 1997). We were interested in taking a similar ap-
proach to define the minimal RUB 3 cis-acting elements
required for negative-strand initiation. The 3-terminal 305
nts of the genome are retained in RUB DI RNAs generated
during undiluted serial passage, implying that the complete
3CSE is located within this region, which includes both 3
end of the SP-ORF and the 60 nt 3UTR (Frey and Hemp-
hill, 1988; Derdeyn and Frey, 1995). Previous mutagenic
analysis using both the genomic and the replicon infectious
cDNA plasmid vectors had shown that the whole region was
necessary for optimal replication but that only the 3UTR
with the exception of the 3-five nucleotides and the poly(A)
tract (which were rapidly regenerated in vivo) is essential
for replication (Chen, 1998; Chen and Frey, 1999), a region
that does not include the calreticulin-binding stem-loop.
However, because most of the 3-305-nucleotide region
encodes E1, extensive mutagenesis of the region could not
be done using an infectious cDNA genomic vector. There-
fore, the ability to segregate this region into a recombination
donor offers the opportunity to test which parts of it are
necessary for negative-strand initiation. Following the de-
sign of the SIN experiments, we cotransfected replicative
transcripts consisting of the genome with the 3UTR either
deleted or replaced with heterologous sequences such as the
SIN 3UTR or nonviral-plasmid vector sequences and non-
replicative transcripts consisting of the 3CSE or 3UTR.
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Because of the cis preference for initiation of negative-
strand synthesis, recombination did not occur following
transfection with Lipofectamine, but with Lipofectamine
2000, recombinants were recovered when the 3CSE but not
the 3UTR was used as the nonreplicative transcript. Hence,
the 3CSE is capable of initiating negative-strand synthesis.
This result may indicate that the 3UTR cannot serve as a
promoter for negative-strand synthesis; however, there was
no sequence overlap between the 3UTR and these replica-
tive transcripts and, as demonstrated with recombinational
templates with minimal overlap in the SP-ORF, some over-
lap appears to be necessary for recombination to occur.
Additionally, although Lipofectamine 2000 allowed for re-
covery of recombinants from R-3UTR/-, R-3SINUTR/-,
and R-3NVS/3CSE cotransfections, appearance of CPE
was delayed to the extent that individual plaques could not
be recognized due to senescence of the monolayer and when
bulk transfection plate culture fluid was harvested and am-
plified, the recombinant virus was found to have the wt 3
sequence (data not shown). In contrast, in similar cotrans-
fections, the SIN 3UTR was found to be able to accom-
modate extensive rearrangements, including the presence of
nonviral sequences. The apparent inability of the RUB
3UTR to tolerate rearrangements would also serve to limit
recombination between replicative transcripts with heterol-
ogous 3UTRs and nonreplicative transcripts consisting of
short 3-terminal fragments. Thus, this experimental model
is not applicable to RUB.
We also investigated recombination in the other region
of the genome that overlapped between the standard repli-
cative–nonreplicative transcript pair, i.e., the 3NS-ORF/J-
UTR/5SP-ORF. Deletion analysis indicated that the pres-
ence of NS-ORF or the SP-ORF in both transcripts was not
necessary for recombination; however, the presence of the
J-UTR in both transcripts was necessary for efficient recom-
bination (i.e., Lipofectamine-mediated transfection) and the
3 end of the J-UTR was essential. This was not due to
minimal overlapping sequence requirements since, despite
the deletions into the J-UTR, an overlap of 482 nts in the
SP-ORF was maintained between the transcripts. Thus, we
hypothesized that the J-UTR was a recombinational hot
spot. To test this hypothesis, the standard cotransfection was
done with transcripts genetically marked on either end of
the J-UTR with a restriction site, NsiI at the 5 end or XbaI
at the 3 end. When XbaI-marked replicative and NsiI-
marked nonreplicative transcripts were used, recombinants
that retained the single site as well as recombinants that had
neither site were recovered, indicating that recombination
both outside the J-UTR (resulting in recombinants with a
single site) and within the J-UTR (resulting in recombinants
with neither site) had occurred. Interestingly, the largest
class of the recombinants had duplications either within the
J-UTR or between the 3NS-ORF and the J-UTR; the latter
recombinants resulted from participation of both regions in
the recombination event. Thus, recombination occurred in
all regions of the overlap between the transcripts. When
NsiI-marked replicative and XbaI-marked nonreplicative
transcripts were used, half of the recombinants had only the
NsiI site and the other half had the XbaI site; to recover the
former recombinant, the recombination event was in the
SP-ORF downstream from the J-UTR, while to recover the
latter recombinant, the recombination was in the NS-ORF
upstream from the J-UTR. A recombination in the J-UTR
would have yielded a recombinant with both restriction sites
and we initially thought that this type of recombinant was
selected against, since recombination in the J-UTR clearly
occurred based on results with the reciprocal transcripts.
However, a Robo502 construct containing both restriction
sites had a wild-type phenotype and the reason for the
asymmetry of recombinant recovery is therefore not clear.
Nevertheless, these results show that recombination can
readily occur outside of the J-UTR. Thus, based on this
experiment, the J-UTR does not appear to be a high-avidity
recombinational hot spot compared to neighboring se-
quences in the NS-ORF and SP-ORF. An alternative hy-
pothesis is that a sequence within the J-UTR is necessary in
the donor template or on both templates for recombination
to occur in this region, whether or not the J-UTR itself is
involved in the recombination event. For example, second-
ary structure in this sequence could interrupt transcription or
this sequence could bind a factor that attracts the RdRp
complex, facilitating strand transfer. In a plant virus system,
it was found that secondary structures that facilitated tem-
plate switching and recombination were also promoters for
RNA replication and bound the viral RdRp (Nagy et al.,
1999). In this regard, in the predicted secondary structure of
the J-UTR, there is a stable stem-and-loop structure (G 
21.24 kcal/mol) formed by the 3 end of the J-UTR (data
not shown).
In the 3 region of the genome, only precise recombi-
nants were recovered, while in the J-UTR region, both
precise recombinants and duplications of varying lengths
were detected. These events have been defined as homolo-
gous and aberrant homologous recombination, respectively
(Lai, 1992). In a study on intramolecular recombination
between SGPs in a double subgenomic vector, both precise
recombinants and recombinants with duplications in the
J-UTR were recovered with the majority being precise re-
combinants (Tzeng and Frey, 2002). In this study, which
covered a larger region of the genome, the duplications
involved only the J-UTR or a combination of the 3NS-ORF
and the J-UTR and thus in all cases the integrity of both the
NS-ORF and the SP-ORF as well as the 3UTR was pre-
served. A similar assortment of recombinants in the J-UTR
was recovered when pairs of transcripts corresponding to
the transcripts used in this study were used in a study on
SIN recombination (Weiss and Schlessinger, 1991). There-
fore, there was apparent selection pressure on maintenance
of both ORFs and the 3UTR. In previous studies, we have
found that while the 3UTR is intolerant of mutagenesis, the
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J-UTR will accommodate extensive manipulation (Chen
and Frey, 1999; Tzeng and Frey, 2002). Presumably, both
precise and imprecise recombinational events occur
throughout the genome, but in most of the genome only
precise recombinants are viable. It is also possible that
duplications caused by imprecise recombination are rapidly
removed by intramolecular recombination, as was the case
with our double subgenomic vectors (Tzeng and Frey,
2002). This could explain the discrepancy observed in
Northern gels of recombinant viruses in which the RNA
species were larger than the standard RNAs, but the dupli-
cations detected by sequencing after an additional passage
were found to be 100 nts (Fig. 1A and B). An evolution
toward the wild-type sequence was also observed with pas-
sage of SIN recombinants with duplications in the J-UTR
region (Weiss and Schlesinger, 1991). Alternatively, dupli-
cations could have been present in other regions of the
genome that did not overlap between the cotransfected tran-
scripts and were not sequenced in the recombinants.
Finally, aberrant homologous recombination events also
allow determination of recombination sites, which are
thought to be associated with secondary structure or regions
of complementarity (Lai, 1992; Nagy and Simon, 1997).
However, the only tendency revealed by analysis of the
exchange sites in aberrant recombinants recovered in this
study was that the donor site was always in a single-
stranded or loop region of the predicted secondary structure.
There was no evidence of complementarity between the
donor and acceptor site.
Materials and methods
Recombinant DNA procedures
Standard recombinant techniques were used throughout
this investigation with minor modifications (Sambrook et
al., 1989). Restriction enzymes were purchased from Pro-
mega (Madison, WI), New England Biolabs (Beverly, MA),
or Roche (Indianapolis, IN) and were used with protocols
and buffers supplied by the manufacturers. Restriction frag-
ments were purified from agarose gels using GeneClean II
(Bio101, Carlsbad, CA) or Qiagen Gel Extraction (Qiagen,
Valencia, CA) kits. Standard PCR reactions consisted of 20
ng of linearized plasmid template, 400 ng of each primer
(primers used for PCR are listed in Table 1), dNTPs (2.5
mM each), and 5 units of Takara Ex Taq DNA polymerase
(PanVera, Madison, WI) in 1 Ex Taq buffer [20 mM
Tris–HCl (pH 8.0), 100 mM KCl, 0.1 mM EDTA, 1 mM
DTT, 0.5% Tween 20, 0.5% Nonidet P-40, and 50% glyc-
erol], 0.05% -mercaptoethanol, and 10% dimethyl sulfox-
ide (DMSO) in a total volume of 50 l. After 30 cycles of
a reaction protocol of 20 s at 95°C for denaturing, 30 s at
50°C for annealing, and 2 min at 72°C for extension fol-
lowed by one cycle of 10 min at 72°C, the reaction products
were analyzed by agarose gel electrophoresis and then pu-
rified using Qiaquick (Qiagen) or Wizard PCR Preps (Pro-
mega, Valencia, CA) kits. The purified PCR products were
restricted with appropriate enzymes prior to ligation. Liga-
tion reactions containing approximately equimolar concen-
trations of DNA fragments and 10 units/l of T4 DNA
ligase (New England Biolabs) in a total volume of 20 l of
1 reaction buffer (50 mM Tris–HCl, pH 7.5, 10 mM
MgCl2, 10 mM dithiothreitol, 1mM ATP, 25 g/ml bovine
serum albumin) supplied by the manufacturer were incu-
bated at 14°C overnight or at room temperature for 1 h. To
replace a restriction fragment in a vector with the corre-
sponding restriction fragment from another vector or a PCR
product with a mutation, the vector was digested with the
appropriate enzymes followed by agarose gel electrophore-
sis. The larger fragment containing the plasmid backbone
was isolated and then ligated with the corresponding restric-
tion fragment isolated from another vector or produced by
PCR amplification.
Vectors and plasmid constructs
Escherichia coli strains MC1061 and JM109 were used
as bacterial hosts. All plasmid constructs were checked by
restriction digestion and sequencing to confirm the correct
ligation of fragments and/or verify the presence of designed
mutations. Automated sequencing was performed using an
ABI PRISM BigDye Terminator Cycle Sequencing Ready
Reaction Kit (PE Applied Biosystems, Foster City, CA) and
appropriate primers. The sequencing reactions were purified
on Centrisep columns (Princeton Separations, Adelphia, NJ)
and then resolved using an ABI 373 sequencer (Perkin–
Elmer Corp, Foster City, CA).
The following RUB cDNA vectors have been described
previously: Robo302/402/502 (infectious cDNA clones us-
ing pCL1921, pBR322, and pUC18 as the backbone vector,
respectively; Pugachev et al., 1997, 2000; Tzeng et al.,
2001; Tzeng and Frey 2002); NRobo402 (Robo402 deriva-
tive with a unique NsiI site immediately downstream from
the NS-ORF at the beginning of the junction UTR; Tzeng
and Frey, 2002); Robo302-35 [Robo302 derivative with a
deletion of the 3-terminal 5 nt preceding the poly (A) tract;
referred to as Robo302–340 in Chen and Frey, 1999];
dsRobo402/GFP (a Robo402 derivative with a second sub-
genomic promoter driving synthesis of a second sub-
genomic RNA from which GFP is expressed; Pugachev et
al., 2000); Robo DI-pas3, DI-Stu, DI-AB, and DI-325 (DI
cDNA vectors with deletions in the SP-ORF; Tzeng et al.,
2001); and RUBrep/GFP (replicon expressing green fluo-
rescent protein in place of the SP-ORF; Tzeng et al., 2001).
XRobo502, a Robo502 derivative with a unique XbaI site
immediately preceding the SP-ORF, was constructed by
first amplifying a PCR product from Robo502 template with
primers 1032 (NsiI and XbaI sites followed by the 5-
fourteen nts of the SP-ORF, nts 6512–6526 of the RUB
genome) and 157 (complementary to nts 6716–6733). Fol-
lowing restriction with NsiI and NotI, this product was used
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to replace the NsiI-NotI fragment of pGEM474, a construct
containing nt 6398 through the EcoRI linearization site of
Robo402 cloned between the NsiI and EcoRI sites of the
MCS of pGEM-11Zf() (see below). The XbaI-EcoRI frag-
ment from this construct was then used to replace the
XbaI-EcoRI fragment of RUBrep/GFP.
The standard replicating vector contained a deletion be-
tween nts 6936 and 9334 of the genome (two StuI sites)
within the SP-ORF. Constructs with this deletion were pro-
duced by digesting a genomic cDNA vector (NRobo502,
XRobo502, Robo302-35) with StuI, isolating the large
fragment containing the vector backbone and 5 and 3 ends
of the Robo cDNA sequences, and religating. Robo302-
3UTR, a Robo302 derivative which lacks the 3UTR but
retains the poly(A) tract, was described previously (as
Robo302–315 in Chen and Frey, 1999). To create a repli-
cating vector that contained nonviral sequences at the 3 end
of the transcripts in place of the 3UTR, PCR was done
using Robo3023UTR template, upstream primer 52b (nts
9174–9187 including a unique BamHI site at nt 9174) and
downstream primer 315-1 (EcoRI site followed by se-
quences complementary to nt 9687–9707, the 3 end of the
SP-ORF). The amplified fragment was restricted with
BamHI and EcoRI and used to replace the corresponding
fragment in Robo302. This vector, Robo302-3NVS, could
be linearized with SspI or SpeI to produce transcripts with
3-terminal nonviral sequences of 357 and 685 nts, respec-
tively, in place of the 3UTR and poly(A) tract. Robo502-
SIN3UTR, a Robo502 derivative which contains the SIN
3UTR in place of the RUB 3UTR, was constructed by
PCR using pTE5ZJ/CAT as a template and upstream
primer 694 (nts 11,302–11,318 of the SIN genome, includ-
ing an MfeI site) and downstream primer 695 (EcoRI site
followed by a T20 tract and sequences complementary to the
3-twenty nts of the SIN genome). The amplified fragment
was restricted with MfeI and EcoRI and inserted at the
EcoRI site in NR-3NVS. Finally, Robo302 5-7318, which
terminates at nt 7318, was generated by digesting Robo302
with AscI and EcoRI [the linearization site following the
poly (A) tract], treating the digested fragments with Klenow
(New England Biolabs) to produce blunt ends, isolation of
the larger DNA fragment containing the vector, and cDNA
sequences from the 5 end through the AscI site by agarose
gel electrophoresis, and self-ligating this fragment.
The standard nonreplicating vector, NR-5355-3, con-
tained the 3 end of the Robo cDNA from nt 5355 through
the 3 EcoRI linearization site following the poly(A) tract in
a pGEM plasmid vector under control of the SP6 RNA
polymerase promoter. NR-5355-3 was constructed by re-
striction of Robo402 with BglII and EcoRI, and the BglII
and EcoRI fragment was used to ligate with BamHI-EcoRI-
restricted pGEM3Z (Promega). NR-5355-35 was con-
structed by replacing the BamHI-EcoRI fragment in NR-
5355-3 with the amplified PCR product from Robo302
template with primers 52 (nts 9163–9180, including a
BamHI site at nt 9174) and 340 [EcoRI followed by oligo
(dT) and sequences complementary to nts 9738–9757]. NR-
5355-3UTR, which lacks the 3UTR (nts 9703–9762) but
contains a poly(A) tract, was constructed by PCR using
Robo302 template, upstream primer 52, and downstream
primer 315 (EcoRI site followed by an T20 tract and se-
quence complementary to nts 9687–9706 of the genome).
The amplification product was restricted with BamHI and
EcoRI and used to replace the corresponding fragment in
NR-5355-3. To create a nonreplicative vector that con-
tained the SIN-3UTR in place of the RUB 3UTR, the
BglII-EcoRI fragment of Robo502-SIN3UTR was intro-
duced into pGEM11Zf(). NR-7318-3, which contains the
3 end of the Robo cDNA sequences from nt 7318 (an AscI
site) through the 3 EcoRI linearization site, was constructed
by annealing T4 polynucleotide kinase (New England Bio-
labs) phosphorylated oligos 518 and 519 to produce an SP6
RNA polymerase promoter flanked by 5 HindIII and 3
AscI overhangs and using this linker to replace the HindIII-
AscI fragment in Robo302. NNR-5355-3 and XNR-
5355-3 were constructed by restricting NRobo502 and
XRobo502, respectively, with BglII and EcoRI and cloning
the BglII-EcoRI fragment into BamHI-EcoRI-restricted
pGEM-11Zf(). NR-3CSE, a construct containing the
3CSE and poly(A) tract, constructed by PCR amplification
using primers 565 (NotI site followed by nts 9457–9471)
and 105 [EcoRI site followed by oligo (dT)] and Robo402
template, restricting the amplification product with NotI and
EcoRI and cloning it into NotI-EcoRI restricted pGEM-
11Zf(). A nonreplicative construct containing the 3UTR
and poly(A) tract, NR-3UTR, was constructed by PCR
amplification using primer 498 (HindIII site followed by a
T7 RNA polymerase promoter and nts 9706–9720 of the
RUB genome) and primer 105 (EcoRI site followed by T20),
restriction of the amplified product with HindIII and EcoRI,
and ligation into HindIII-EcoRI restricted pUC18.
NR-6263-3, NR-6313-3, pGEM-474, NR-6408-3,
NR-6436-3, and NR-6462-3 were constructed by digestion
of dsRobo402/GFP, dsRobo402/GFP/B438, dsRobo402/
GFP/B474, dsRobo402/GFP/B440, dsRobo402/GFP/B441,
and dsRobo402/GFP/B442, respectively (Tzeng and Frey,
2002), with NsiI and EcoRI and cloning the NsiI-EcoRI
fragment into NsiI-EcoRI-restricted pGEM-11Zf(). A se-
ries of constructs containing sequential deletions of the SGP
was made by PCR using Robo402 template, a mutagenic
upstream primer consisting of an NsiI site followed by 15
nts of the RUB genome downstream from the deletion site,
and downstream primer 157 (complementary to nts 6716–
6733, downstream from a NotI site at nt 6622). The ampli-
fied fragment was restricted with NsiI and NotI and used to
replace the corresponding fragment in pGEM474. The con-
structs (the number corresponds to the nt of the genome at
which the RUB sequences begin) and upstream mutagenic
primers used in their construction were as follows:
Robo36467, primer 993; Robo36473, primer 995;
Robo36479, primer 994; Robo36486, primer 963;
Robo36651, primer 964; Robo36751, primer 965;
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Robo36851, primer 966; and Robo36951, primer 967.
Additionally, Robo36622 was constructed by digesting
pGEM474 with NotI and EcoRI and cloning the NotI-EcoRI
fragment into pGEM-11Zf().
In vitro transcription, transfection, and infection
All plasmids used for in vitro transcription were purified
by cesium chloride isopycnic gradient centrifugation (Sam-
brook et al., 1989). For each construct, one plasmid clone
with the desired manipulation or mutation confirmed by
sequencing was used for in vitro transcription and subse-
quent transfection. Plasmids were linearized with EcoRI
prior to transcription (with the exception of Robo302-
3NVS, which was linearized with SspI or SpeI). One mi-
crogram of linearized template plasmid was used in each
transcription reaction. Transcription reactions with SP6 or
T7 RNA polymerase in the presence of cap analog were
done as previously described (Pugachev et al., 1997; Chen
and Frey, 1999) followed by digestion with RNase-free
DNase (1 U/l) (Promega) for 30 min at 37°C and phenol–
chloroform extraction. The resulting transcripts were ana-
lyzed by agarose gel electrophoresis and relative concentra-
tions were approximated by estimating the intensity of the
RNA bands after ethidium bromide staining. Aliquots of
reaction mixtures were used directly for transfection.
Transfection was performed on 80–95% confluent
Vero cells grown at 35°C in 35-mm2-diameter plates in
Dulbecco’s minimal essential medium (DMEM) (Gibco-
BRL, Gaithersburg, MD) supplemented with 5% fetal bo-
vine serum (5%FBS-DMEM) and gentamycin (10 g/ml).
The cells were washed twice with phosphate-buffered saline
(PBS) and once with Opti-MEM I (Gibco-BRL) and trans-
fected with a mixture that contained 200 l Opti-MEM I
(Gibco-BRL), approximately equal amounts of each RNA
transcript (4–7 l of each transcript), and 5 l of Lipo-
fectamine reagent or Lipofectamine 2000 (Gibco-BRL). Af-
ter mixing, the transfection mixture was incubated for 45
min at room temperature followed by addition of 0.8 ml
Opti-MEM I to the washed cells. For the lipofectamine-
mediated transfection, the cells were incubated for 3 to 5 h
at 35°C and then 1 ml of 5% FBS-DMEM was added to the
cells. The transfection mixture was removed after overnight
incubation and replaced with 3 ml of 2% FBS-DMEM and
the cells were monitored daily for development of CPE. For
Lipofectamine 2000 mediated transfection,95% confluent
cells were used and, following addition of the transfection
mixture, cells were incubated for 3–5 h before the transfec-
tion mixture was removed and replaced with 2% FBS-
DMEM and monitored daily for development of CPE. After
the detection of CPE, transfected culture supernatants were
harvested and 250 l was used to infect fresh Vero cells
which were then incubated and monitored for appearance of
CPE to confirm the presence of virus.
Where indicated, transfections were done using 60-mm2
plates and after a 3–4 h incubation with the transfection
mixtures, the cells were overlaid with plaque assay agar
[MEM containing 1% FBS, 0.1% DEAE dextran, 0.1%
penicillin/streptomycin, and 0.4% agar (Oxoid agar No. 1;
Ogdensburg, NY)]. Single plaques were located by micros-
copy and excised, and virus was eluted in 500 l DMEM at
4°C overnight, followed by one round of amplification in
Vero cells. Additionally, where indicated, culture fluid in
transfected cells maintained in liquid medium was passaged
after appearance of CPE, as described, to fresh cells which
were then overlaid with agar after a 1-h adsorption.
Analysis of virus-specific RNA produced by recombinant
viruses
Total cellular RNA was extracted from monolayers of
infected Vero cells 4–8 days postinfection (corresponding
to appearance of CPE) with RNA Wiz (Ambion, Inc., Aus-
tin, TX) following the manufacturer’s protocol. RNA ex-
tracted from a 35-mm2 plate of Vero cells was dissolved in
20 to 50 l of diethylpyrocarbonate-treated water and stored
at 70°C. Northern analysis was done as previously de-
scribed (Tzeng et al., 2001) using NR-6622-3 that was
32P-labeled by nick-translation. To sequence the regions of
the genome in recombinant viruses that overlapped in the
transcripts used in cotransfection, RT-PCR followed by
automated sequencing of the amplification product was em-
ployed; the primer pairs used for RT-PCR and sequencing
are listed in Table 2. The negative-sense primer (50 or 100
ng) was annealed at 55°C with 5 l of the extracted RNA
template in Superscript Reverse Transcriptase buffer [50
mM Tris–HCl (pH 8.3), 75 mM KCl, 3 mM MgCl2] (Gibco–
BRL) in enzyme-free water for 2 min followed by addition
of 100 mM DTT, 20 mM of each deoxynucleotide triphos-
phate (dNTPs), 1 l RNase inhibitor (RNasin, 40 U/l), and
1 l SuperscriptII Reverse Transcriptase (200 U/l) in a
total volume of 20 l. The reaction mixture was incubated
for 60 min at 45°C and 1 l RNaseH (0.5–2 U/l) was then
added to the reaction mixture and incubation was continued
for 30 min at 37°C, at the end of which time 5 l was used
for PCR amplification using the paired positivex and nega-
tive-sense primers listed in Table 2. Cycle sequencing of the
amplified PCR product was done as described above.
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Table 2
Oligonucleotides used in this study
Number (polarity)a Sequence (5-3) Propertiesb
Vector Constructionc
1032 () GCATATGCATCTAGAATGGCTTCTACTACC NsiIXbaI followed by 6512–6526
157 () CGCGGATCCTACTACCAGTCCCTGCGCTGGCC BamHI followed by c6716–6733
52b () CGGGATCCACGCCCAC 9174–9187 including BamHI
315-1 () CGTGAATTCCCACTAGCGCGGCGCTATAG EcoRI followed by c9687–9707
694 () ACACCAATTGTTTTCGGCGGCGCCTCG 11302–11318 (SIN) including MfeI
695 () CGGAATTCT20GAAATGTTAAAAACAAAATTT EcoRI followed by oligo-dT and c11687–11703 (SIN)
326 () GAGATCTTCGCCGGCATGT 5354–5372 including BglII
105 () ACGTGAATTCT20 EcoRI followed by oligo-dT
52 () AATGCCCGAGTGGATCCA 9163–9180 including BamHI
340 () CGTGAATTCT20CAGCAACAGGTGCGGGGATC EcoRI followed by oligo-dT and c9738–9757
52 () AATGCCCGAGTGGATCCA 9163–9180 including BamHI
315 () CGTGAATTCT20CCACTAGCGCGGCGCTATAG EcoRI followed by oligo-dT and c9687–9706
518 () AGCTTATTTAGGGG HindIII 5 overhang followed by SP6 promoter
519 () CGCGCCCCTAAATA AscI 5 overhang followed by cSP6 promoter
565 () GCATGCGGCCGCTGCGGGGGCGAGAG NotI followed by 9457–9471
105 () ACGTGAATTCT20 EcoRI followed by oligo-dT
498 () TCGAAGCTTAATACGACTCACTATAGGCCCCCGCGCGAA HindIII, T7 promoter followed by 9706–9720
105 () ACGTGAATTCT20 EcoRI followed by oligo-dT
963 () CCCCCATGCATATTCGGGAGAGCCCC NsiI followed by 6486–6499
964 () CCCCATGCATCCTCCGGAGATGACTCCG NsiI followed by 6651–6671
965 () CCCCATGCATCCCGGAGGAGCGGCAAGAA NsiI followed by 6751–6771
966 () CCCCATGCATGGGGGCTCTGCCCCGCG NsiI followed by 6851–6867
967 () CCCCATGCATAGGCACCCACCGAGGCCTGC NsiI followed by 6951–6970
993 () CCCCATGCATTGGGTACCCAACTTTTG NsiI followed by 6467–6483
994 () CCCCATGCATTTTTGCCATTCGGGAG NsiI followed by 6479–6494
995 () CCCCATGCATCCCAACTTTTGCCATTC NsiI followed by 6473–6489
RT-PCR 3 end of genomed
F1 () CGCGAATTC(T)20CTATACAGCAACAGGTGC EcoRI followed by oligo-dT and c9745–9762
52 () AATGCCCGAGTGGATCCA 9163–9180 including BamHI
F1 () CGCGAATTC(T)20CTATACAGCAACAGGTGC EcoRI followed by oligo-dT and c9745–9762
52b () GGGATCCACGCCCAC 9174–9182 including BamHI
105 () ACGTGAATTCT20 EcoRI followed by oligo-dT
52 () AATGCCCGAGTGGATCCA 9163–9180 including BamHI ()
105 () ACGTGAATTCT20 EcoRI followed by oligo-dT
52b () GGGATCCACGCCCAC 9174–9182 including BamHI
216 () CCGGTCTAGACTATACAGCAACAGGTGCGGCAATCT XbaI followed by c9737–9762
52 () AATGCCCGAGTGGATCCA 9163–9180 including BamHI
3NS-ORF/J-UTR/5SP-ORF
325 () CGGGATCCCCGGCGCGCGCGGTG BamHI followed by c7399–7413
173 () CCGGAATTCCGACTACAGCGCGGAGC EcoRI followed by 6244–6260
197 () CACGAAGCTTGTGCCTCGAGGGCCTTC HindIII followed by c6550–6566
177 () CCGGAATTCGGTGCTTTGCCGCCGTT EcoRI followed by 6124–6140
550 () CGCAGGCCTCGGTGGGTG c6954–6971 including StuI
362 () GCCCTTTTCGCCAGATCC 5196–5213
1033 () GTACTCTAGATTCGGGCACCCTGGGGCTC XbaI followed by c6494–6512
715 () GCATGCGGCCGCTTTTCGCCAGATCCC NotI followed by 5200–5214
159 () CGCGGATCCTACTAAAAGACCGCGCCTTCGCC BamHI followed by c6995–7014
177 () CCGGAATTCGGTGCTTTGCCGCCGTT HindIII followed by 6124–6140
a Restriction sites (underlined), RNA polymerase promoters (italics) and colinear or complementary (c) sequences of the RUB (no designation) or SIN
genome included in the oligonucleotide primer are given. () polarity primers are colinear with the genomic RNA sequence while () polarity primers are
complementary.
b The oligonucleotide primer pairs used to generate individual vector constructs, in order as described in the Methods section, are paired by brackets.
c Oligo primers 963–967 () and 993–995 () were each used with oligo 157 () in vector construction.
d The bracketed oligonucleotide primer pairs were used for RT-PCR to amplify regions of the genome of recombinant viruses that overlapped in the
parental transcripts, the 3 end of the genome and the regions containing the 3 end of the NS-ORF, the J-UTR, and the 5 endof the SP-ORF (see Fig. 1).
The amplification products were then used for sequencing.
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